文献速递乳腺MR

基于多参数MRI的影像组学特征用于乳腺癌患者术前预测HER2状态

Radiomics Signatures Based on Multiparametric MRI for the Preoperative Prediction of the HER2 Status of Patients with Breast Cancer.
PubMed 文献 · Acad Radiol · 2020-07-22

本研究回顾性纳入306例非特殊型浸润性导管癌患者,从压脂T2加权和DCE-T1术前MRI提取影像组学特征,用支持向量机构建单参数及联合参数特征预测HER2状态;联合模型在主要队列和验证队列AUC分别为0.86和0.81,提示多参数MRI影像组学可作为评估乳腺癌HER2状态的潜在工具。

要点

  • 压脂T2、DCE-T1及两者联合的影像组学特征均可区分HER2阳性与阴性乳腺癌。
  • 联合压脂T2与DCE-T1的多参数模型主要队列AUC 0.86,验证队列AUC 0.81。
  • 单参数模型中压脂T2主要队列AUC 0.74,DCE-T1主要队列AUC 0.71。

核心结论

  • 基于多参数MRI的影像组学特征可能是评估乳腺癌患者HER2状态的潜在且有效的替代工具。

研究设计与样本

  • 回顾性纳入306例非特殊型浸润性导管癌(IDC-NST)患者。
  • 从术前压脂T2加权和动态对比增强T1加权(DCE-T1)MRI提取定量影像特征。
  • 使用支持向量机(SVM)分别构建基于压脂T2、DCE-T1及两者联合的三种影像组学特征,以预测HER2阳性与阴性状态。
  • 采用AUC、准确率、敏感度和特异度评估特征预测性能,并在主要队列和验证队列中验证。

诊断标准与关键数值

  • 共28个定量影像组学特征用于构建特征,包括14个纹理特征、4个一阶特征、9个小波特征和1个形状特征。
  • 压脂T2特征区分HER2阳性与阴性的AUC在主要队列为0.74(95%CI 0.700–0.770),验证队列为0.70(95%CI 0.666–0.744)。
  • DCE-T1特征区分HER2阳性与阴性的AUC在主要队列为0.71(95%CI 0.673–0.738),验证队列为0.68(95%CI 0.650–0.726)。
  • 联合特征区分HER2阳性与阴性的AUC在主要队列为0.86(95%CI 0.832–0.882),验证队列为0.81(95%CI 0.776–0.837)。

临床应用与阅片要点

  • 原文结论认为基于多参数MRI的影像组学特征可能是评估乳腺癌HER2状态的潜在且有效的替代工具。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: The aim of our study was to preoperatively predict the human epidermal growth factor receptor 2 (HER2) status of patients with breast cancer using radiomics signatures based on single-parametric and multiparametric magnetic resonance imaging (MRI).

METHODS: Three hundred six patients with invasive ductal carcinoma of no special type (IDC-NST) were retrospectively enrolled. Quantitative imaging features were extracted from fat-suppressed T2-weighted and dynamic contrast-enhanced T1 weighted (DCE-T1) preoperative MRI. Then, three radiomics signatures based on fat-suppressed T2-weighted images, DCE-T1 images and their combination were developed using a support vector machine (SVM) to predict the HER2-positive vs HER2-negative status of patients with breast cancer. The area under the curve (AUC), accuracy, sensitivity, and specificity were calculated to assess the predictive performances of the signatures.

RESULTS: Twenty-eight quantitative radiomics features, namely, 14 texture features, 4 first-order features, 9 wavelet features, and 1 shape feature, were used to construct radiomics signatures. The performance of the radiomics signatures for distinguishing HER2-positive from HER2-negative breast cancer based on fat-suppressed T2-weighted images, DCE-T1 images, and their combination had an AUC of 0.74 (95% confidence interval [CI], 0.700 to 0.770), 0.71 (0.673 to 0.738), and 0.86 (0.832 to 0.882) in the primary cohort and 0.70 (0.666 to 0.744), 0.68 (0.650 to 0.726), and 0.81 (0.776 to 0.837) in the validation cohort, respectively.

CONCLUSION: Radiomics signatures based on multiparametric MRI represent a potential and efficient alternative tool to evaluate the HER2 status in patients with breast cancer.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Zhou J, Tan H, Li W, et al. Radiomics Signatures Based on Multiparametric MRI for the Preoperative Prediction of the HER2 Status of Patients with Breast Cancer. Acad Radiol. 2020. PMID: 32709582. doi:10.1016/j.acra.2020.05.040

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。